# Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

> **NCT00842673** · PHASE2 · COMPLETED · sponsor: **Sonexa Therapeutics, Inc.** · enrollment: 168 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** ST101
- **DRUG:** ST101
- **DRUG:** ST101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00842673
- **Lead sponsor:** Sonexa Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842673, "Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00842673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*